Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Advanced Materials (Deerfield Beach, Fla.)|March 14, 2023
Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer ImmunotherapyBoda Guo, Feiya Yang, Lingpu Zhang, et al.Biomaterials|March 11, 2026
A coenzyme-based "interface-welding" hydrogel coating for titanium implants promotes diabetic osseointegration by regulating mitochondrial dynamicsQiaojian Duan, Wenbo Geng, Tingting He, et al.Cancer Letters|July 6, 2023
TIGIT immune checkpoint blockade enhances immunity of human peripheral blood NK cells against castration-resistant prostate cancerFangming Wang, Shuai Liu, Fei Liu, et al.Biomedicines|April 29, 2025
Comprehensive Integrated Analysis Reveals the Spatiotemporal Microevolution of Cancer Cells in Patients with Bone-Metastatic Prostate CancerYinghua Feng, Xiuli Zhang, Guangpeng Wang, et al.Iscience|January 5, 2024
Notch activation defines immune-suppressive subsets of ccRCCs with unfavorable benefits from immunotherapy over VEGFR/mTOR inhibitorsSujun Han, Yu Xu, Dong Chen, et al.Discover Oncology|July 28, 2025
Metabolomic Understanding of variable risk factors for kidney cancer: a two-sample Mendelian randomization studyYihao Zhu, Ke Wang, Yuan Yu, et al.Chinese Medical Journal|August 23, 2024
Preliminary clinical practice of radical prostatectomy without preoperative biopsyRanlu Liu, Lu Yin, Shenfei Ma, et al.European Urology Open Science|November 11, 2025
Efficacy and Safety of Xialiqi for the Treatment of Benign Prostatic Hyperplasia in a Randomized TrialFeiya Yang, Chao Yang, Xin Wang, et al.Scientific Reports|February 26, 2025
Role of PLA2R domain antibodies and epitope spreading in risk stratification and prediction of proteinuria remission in primary membranous nephropathyXiran Zhang, Feiya Yang, Yun Fan, et al.Advanced Healthcare Materials|October 13, 2024
Targeting Hypoxia and Autophagy Inhibition via Delivering Sonodynamic Nanoparticles With HIF-2α Inhibitor for Enhancing Immunotherapy in Renal Cell CarcinomaYihao Zhu, Yajian Li, Xuwen Li, et al.Pageof 7